| Product Information |
|
| Registration Number |
DR-XY47160
|
| Generic Name |
Doxorubicin hydrochloride
|
| Brand Name |
Caelyx
|
| Dosage Strength |
2 mg/mL
|
| Dosage Form |
Pegylated Liposomal Concentrate
Suspension for Solution for Injection for I.V.
Infusion
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
Type I clear glass tubing vial with bromobutyl
stopper and aluminum seal with flip-off cap x 10 mL and 25 mL (net content). Box of 1's
|
| Manufacturer |
GlaxoSmithKline Manufacturing S.P.A.
|
| Country of Origin |
Italy
|
| Trader |
|
| Importer |
Johnson & Johnson (Phils.) Inc.
|
| Distributor |
|
| Application Type |
-
|
| Issuance Date |
02 February 2021
|
| Expiry Date |
02 February 2026
|